CD&R Pays $10.3B for Sealed Air in Rare Industrial Packaging Carveout
Private equity takes bubble wrap and Cryovac offline amid quiet consolidation in B2B materials infrastructure.
Clayton, Dubilier & Rice agreed to acquire Sealed Air Corporation for $10.3 billion, removing the 68-year-old packaging manufacturer from public markets in one of the year's largest industrial buyouts. The deal values Sealed Air at roughly $386 per share, a 28% premium to its 30-day volume-weighted average price, and marks CD&R's third packaging-sector transaction since 2021.
Sealed Air controls 35% of the North American protective packaging market through brands including Bubble Wrap, Cryovac, and Autobag. The Charlotte-based company generated $5.5 billion in revenue over the trailing twelve months, with $980 million in adjusted EBITDA. CD&R is paying approximately 10.5x trailing EBITDA, a multiple that reflects both defensive end-market exposure and the operational complexity of integrating legacy assets across 115 manufacturing facilities in 63 countries. The transaction is structured as an all-cash offer funded through a combination of equity from CD&R Fund XIII and committed debt financing from JPMorgan and Bank of America.
The acquisition reflects a specific thesis on B2B packaging infrastructure that has currency only in private markets. Sealed Air's customer base—food processors, e-commerce fulfillment centers, industrial distributors—operates on multi-year contracts with quarterly price adjustments tied to resin input costs. Revenue visibility is high, but public equity markets penalized the stock for low single-digit organic growth and capital intensity required to shift production toward sustainable materials. CD&R is betting it can extract $200-250 million in run-rate cost synergies by consolidating the North American plant footprint and renegotiating procurement agreements that were last rebid in 2019. The firm has precedent: its 2018 take-private of Solenis, a specialty chemicals supplier, delivered a 2.8x gross multiple after similar operational restructuring.
Two dynamics matter for allocators tracking industrials. First, this is the fourth packaging take-private above $5 billion since 2022, following Advent's acquisition of Flex Films, Apollo's purchase of Novolex, and Bain's carveout of Tekni-Plex. The pattern is consistent: single-digit growth businesses trading at 8-12x EBITDA in public markets, repriced at 10-14x by sponsors who see 400-600 basis points of margin expansion over three to four years. Second, Sealed Air's divestiture cycle is complete. The company sold its Diversey cleaning-products division to Bain for $4.2 billion in 2021, its Liquibox beverage-packaging unit to Apollo in 2020, and has spent the past 18 months defending against activist pressure to accelerate share buybacks. CD&R's offer removes that governance friction and resets the capital-allocation framework around private-market return hurdles.
Operators should watch CD&R's disclosure of the debt package within 45 days and whether the firm syndicates any equity to sovereign wealth funds, a pattern visible in its recent Cubic Transportation and Belron deals. The packaging sector's consolidation clock is also running: Berry Global and Sonoco remain public, both trading below 9x forward EBITDA, both with overlapping customer bases in food and medical end markets. If CD&R achieves its cost targets at Sealed Air by mid-2026, those two become logical bolt-on candidates or standalone LBO targets for firms with industrial playbooks.
The transaction closes in Q2 2025, subject to regulatory clearance and shareholder approval that is effectively guaranteed given the premium. Sealed Air's management stays intact under CEO Emile Chammas, who joined in 2023 from Amcor and spent six months preparing the company for exactly this outcome.